Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials
Johannes F.E. Mann, Thomas K. Hansen, Thomas Idorn, Lawrence A. Leiter, Steven P. Marso, Peter Rossing, Jochen Seufert, Sayeh Tadayon, Tina Vilsbøll
Topics & Concepts
SemaglutideMedicinePost-hoc analysisType 2 diabetesRenal functionDiabetes mellitusPost hocMEDLINERandomized controlled trialInternal medicineEndocrinologyLiraglutidePolitical scienceLawDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesDiabetes Management and Research